References
J. H. Butera, W. Spinelli, V. Anantharaman, et al.,J. Med. Chem.,34(11), 3212 - 3228 (1991).
E. M. Vaughan-Williams,J. Clin. Pharmacol.,24(4), 129 - 147 (1984).
USSR Pat. No. 1833612.
R. A. Marinchak, K. M. O'Connor, T. D. Friehling, P. R. Kovey, et al.,J. Cardiovasc. Pharmacol.,4, 389 - 395 (1989).
Z. N. Vedeneeva,Farmakol. Toksikol.,18(5), 3 - 8 (1995).
M. R. Malinow, F. F. Batli, and J. Malamud,Arch. Int. Pharmacodyn.,102, 55 - 69 (1955).
E. M. Vaughan-Williams and A. Sekiya,Lancet,1, pp. 420 - 421 (1963).
M. L. Belen'kii,Elements of Quantitative Assessment of Pharmacological Effect [in Russian], Leningrad (1963).
L. Szekeres and G. J. Papp,Experimental Cardiac Arrhythmias and Antiarrhythmic Drugs, Budapest (1971), pp. 24–93.
C. L. Miller and M. L. Tainter,Proc. Soc. Exp. Biol. (N.-Y),75, 261 - 268 (1944).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mashkovskii, M.D., Glushkov, R.G., Dorodnikova, E.V. et al. Search for antiarrhythmic drugs among 1,5-diaminopentane derivatives. Pharm Chem J 29, 181–185 (1995). https://doi.org/10.1007/BF02219062
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02219062